Biotechnology in Europe - Research and Markets

Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

Biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications. Market value refers to the revenue generated from product sales, licensing fees, royalties, and research funding.
The European biotechnology market recorded revenues of $226.4 billion in 2024, representing a compound annual growth rate (CAGR) of 4.2% between 2019 and 2024.
The medical/healthcare segment accounted for the market's largest proportion in 2024, with total revenues of $157.6 billion, equivalent to 69.6% of the market's overall value.
The European biotechnology market is experiencing unprecedented growth, fueled by a surge in equity financing and venture capital investments. According to the UK Bio Industry Association (BIA), in 2024, the UK biotech and healthcare market saw an annual increase of 94% in equity financing, raising around GBP3.5 billion ($4.4 million).

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe
Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts

Reasons to Buy

What was the size of the Europe biotechnology market by value in 2024?
What will be the size of the Europe biotechnology market in 2029?
What factors are affecting the strength of competition in the Europe biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up Europe's biotechnology market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the key players?
7.2. What strategies do the key players follow?
7.3. What have been the most recent market developments?

8 Company Profiles

8.1. AstraZeneca Plc
8.2. Novartis AG
8.3. Bayer AG
8.4. Novo Nordisk AS

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: Europe biotechnology industry value: $ million, 2019-24
Table 2: Europe biotechnology industry category segmentation: % share, by value, 2019-24
Table 3: Europe biotechnology industry category segmentation: $ million, 2019-24
Table 4: Europe biotechnology industry geography segmentation: $ million, 2024
Table 5: Europe biotechnology industry value forecast: $ million, 2024-29
Table 6: AstraZeneca Plc: Key Facts
Table 7: AstraZeneca Plc: Annual Financial Ratios
Table 8: AstraZeneca Plc: Key Employees
Table 9: Novartis AG: Key Facts
Table 10: Novartis AG: Annual Financial Ratios
Table 11: Novartis AG: Key Employees
Table 12: Bayer AG: Key Facts
Table 13: Bayer AG: Annual Financial Ratios
Table 14: Bayer AG: Key Employees
Table 15: Bayer AG: Key Employees Continued
Table 16: Bayer AG: Key Employees Continued
Table 17: Novo Nordisk AS: Key Facts
Table 18: Novo Nordisk AS: Annual Financial Ratios
Table 19: Novo Nordisk AS: Key Employees
Table 20: Europe Size of Population (Million), 2019-24
Table 21: Europe Real GDP (Constant 2010 Prices, $ Billion), 2019-24
Table 22: Europe GDP (Current Prices, $ Billion), 2019-24
Table 23: Europe Inflation, 2019-24
Table 24: Europe Consumer Price Index (Absolute), 2019-24
Table 25: Europe Exchange Rate, 2019-24

List of Figures

Figure 1: Europe biotechnology industry value: $ million, 2019-24
Figure 2: Europe biotechnology industry category segmentation: $ million, 2019-24
Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2024
Figure 4: Europe biotechnology industry value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the biotechnology industry in Europe, 2024
Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2024
Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2024
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2024
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2024
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

AstraZeneca Plc
Novartis AG
Bayer AG
Novo Nordisk AS

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€320EUR$350USD£269GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€481EUR$525USD£403GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€641EUR$700USD£537GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Europe Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

Bioengineered Protein Drugs Market Report 2025

Global Biotechnology

Biotech Market 2025-2029

Large and Small-Scale Bioprocessing Market Report 2025